Trades on 2 secondary markets

EpiBiologics

EpiBiologics is a clinical-stage biotechnology company based in San Mateo, California, developing bispecific antibodies for directed extracellular protein degradation. Its proprietary EpiTAC platform leverages an atlas of 270+ degradation-inducing cell-surface receptors to build tissue-selective the

minimal 8.4 / 100 0 APIs View provider profile →

Company Life Sciences Biotechnology Therapeutics Drug Discovery Protein Degradation

EpiBiologics is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.

Where It Trades

EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.